Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: NEJM Evid. 2022 Sep 13;1(10):10.1056/evidoa2200091. doi: 10.1056/evidoa2200091

Figure 2. Kaplan–Meier Survival Curves in the TOPCAT trial.

Figure 2.

Kaplan–Meier survival curves for tertiles of plasma endotrophin (ET) for (Panel A) the primary end point, (Panel B) all-cause death or heart failure–related hospital admission (DHFA), and (Panel C) all-cause death in the Treatment of Preserved Cardiac Function HF with an Aldosterone Antagonist trial.